GlaxoSmithKline: all 4,196 studies
Page 28 of 42. Open to participants first (141), then studies with results posted, then the rest; newest registration first within each.
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Inhaled GSK1995057CompletedNCT01587807Phase 1
- WEUKBRE5555: IMI PROTECT(Work Package 2): Liver Injury & AntibioticsCompletedNCT01587768
- IMI PROTECT (Work Package 2): Calcium Channel Blockers and CancerCompletedNCT01587742
- IMI PROTECT(WP2): Antidepressants & FracturesCompletedNCT01587729
- A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2339345.CompletedNCT01587716Phase 1
- Use of Beta-blockers and Risk of New Onset DiabetesCompletedNCT01587638
- Systematic Review: Retigabine for Adjunctive Therapy in Partial EpilepsyCompletedNCT01587339
- Rechallenge, Potential Drug Induced Liver Injury (Kaiser)CompletedNCT01584765
- An Open-label, Single-centre Study Evaluating the Pharmacokinetics of Digoxin Alone and When Administered at Various Doses of Ezogabine/Retigabine in Healthy Adults. The Pharmacokinetics of Ezogabine/Retigabine and the N-acetyl Metabolite of Ezogabine/Retigabine (NAMR) Will Also be AssessedCompletedNCT01583036Phase 1
- A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of of GSK2118436 in Japanese Subjects With BRAF Mutation Positive Solid TumorsCompletedNCT01582997Phase 1
- Study to Compare the Bioavailability of Dutasteride Novel Formulation Form to the Soft Gel Capsule Form in Healthy Male SubjectsCompletedNCT01577693Phase 1
- A Study to Assess the Effects of GSK573719/VI Combination and GSK573719 Monotherapy in Subjects With Moderate Hepatic Impairment and Matched Healthy VolunteersCompletedNCT01577680Phase 1
- A Repeat Dose Study in Healthy Volunteers Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK356278CompletedNCT01573819Phase 1
- Study to Assess the Safety and PK of GSK573719 and GSK573719/GW642444(VI) Combination in Healthy Subjects and Subjects With Severe Renal ImpairmentCompletedNCT01571999Phase 1
- A First-time-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of GSK189075A in Healthy Subjects and in Subjects With Type 2 Diabetes MellitusCompletedNCT01571661Phase 1
- A Study Investigating the Pharmacokinetic Profiles of Four Extended Release Paracetamol FormulationsCompletedNCT01568749Phase 1
- Post-marketing Surveillance to Assess the Safety of Infanrix-IPV Vaccine Among Infants and Children in KoreaCompletedNCT01568060
- Randomised, Double-blind, Placebo-controlled Study of Topical Clobetasone Butyrate 0.05% Cream in Subjects With Eczema for Two Weeks to Evaluate the Efficacy and SafetyCompletedNCT01567995Phase 3
- A Study to Evaluate the Effect of Boceprevir and Telaprevir on Dolutegravir Pharmacokinetics in Healthy Adult Subjects (ING115697).CompletedNCT01563328Phase 1
- Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2010-2011CompletedNCT01563159
- Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2006-2007CompletedNCT01563146
- A Single Dose Pharmacokinetics (PK) Study of GSK2434735 in Healthy Male VolunteersCompletedNCT01563042Phase 1
- At What Time Therapeutic Plasma Concentrations of Paracetamol Are Achieved in Two Marketed FormulationsCompletedNCT01551836Phase 1
- A Pharmacokinetic Study to Compare Sustained Release and Standard Paracetamol Formulations.CompletedNCT01551797Phase 1
- GW824575 First Time in HumanTerminatedNCT01551771Phase 1
- Post-marketing Surveillance of GSK Biologicals' Cervarix™ When Administered to Healthy Females in Sri LankaWithdrawnNCT01551537
- A Study to Assess the Pharmacologic Equivalence of Two Orlistat Dosage FormsCompletedNCT01550926Phase 1
- Cardiovascular Events in Parkinson's Disease PatientsCompletedNCT01545856
- A Study to Determine the Safety, Tolerability, and Effects of GSK2374697 in Healthy VolunteersCompletedNCT01545570Phase 1
- Pharmacokinetic Study Investigating the Extent of Paracetamol Absorption From a New Formulation of Paracetamol Compared With Panadol®CompletedNCT01540734Phase 1
- Pharmacokinetic Study Investigating the Extent of Paracetamol Absorption From a New Formulation of Paracetamol Compared With Panadol® ExtendCompletedNCT01540721Phase 1
- A Single Centre Study in Healthy Volunteers to Optimise the Rotacap Formulation and ROTAHALER Device for Delivery of Fluticasone Propionate/SalmeterolCompletedNCT01540708Phase 1
- Dolutegravir Expanded Access StudyCompletedNCT01536873Not applicable
- Bioequivalence of Two Levothyroxine Tablet Formulations in Healthy Indian VolunteersCompletedNCT01536678Phase 4
- Belimumab (BENLYSTA®) Pregnancy RegistryCompletedNCT01532310
- A Study to Evaluate the Pharmacokinetics of Benzoic Acid and Hippuric Acid After Topical Administration of GSK2585823 in Japanese Subjects With Acne VulgarisCompletedNCT01527123Phase 1
- Cost of Illness Associated With Influenza in the UKCompletedNCT01521416
- Assessment of Lung Function After Single Inhalations of a Bronchodilator From 2 Configurations a Dry Powder Inhaler.CompletedNCT01521390Phase 1
- QTc Study GSK573719+GW642444CompletedNCT01521377Phase 1
- Study to Estimate the Burden of Herpes Zoster and Postherpetic Neuralgia in SpainCompletedNCT01521286
- Influenza Burden Assessment in the United Kingdom, 1996-2008CompletedNCT01520935
- Assessment of Comorbidities in Chronic Obstructive Pulmonary Disease (COPD) in European Symptomatic Subjects From Primary CareCompletedNCT01516528
- Japanese phase1 Study of Belimumab (IV vs SC)CompletedNCT01516450Phase 1
- Serological Response to Porcine Circovirus Type 1 (PCV-1) and PCV-1 DNA in Stools of Infants Following Administration of Rotarix™CompletedNCT01511133
- A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular EdemaCompletedNCT01506895Phase 2
- A Study of GW685698X 100mcg Administered Once Daily Either in the Morning or the Evening and GW685698X 250mcg Administered Once Daily in the Evening Via DISKHALER for 28 Days in Subjects With Persistent Bronchial Asthma.CompletedNCT01499446Phase 2
- Drug Interaction Study Between Dolutegravir and an Oral Contraceptive Containing Norgestimate and EthinylestradiolCompletedNCT01498861Phase 1
- Cervarix Long-term Safety SurveillanceCompletedNCT01498627
- A Multiple Use Tolerability Study of a Breathe Right Nasal Strip PrototypeCompletedNCT01495494Phase 1
- A Study to Evaluate Single and Repeat Doses of IV GSK2251052 in Healthy Male Japanese and Caucasian Subjects and Repeat Doses of Supratherapeutic Doses of IV GSK2251052 in Healthy VolunteersTerminatedNCT01495065Phase 1
- A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East AsiaCompletedNCT01495026Phase 1
- A Comparison of Atorvastatin and Glimepiride Fixed Dose Combination and Atorvastatin and Glimepiride Loose Combination in the Treatment of Patients With Type 2 Diabetes MellitusCompletedNCT01495013Phase 3
- The Safety, Tolerability, PK and PD of GSK2339345 in Healthy SubjectsCompletedNCT01494636Phase 1
- A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult SubjectsCompletedNCT01489943Phase 1
- Bioequivalence Study to Compare Fluticasone Furoate (FF) 1-strip Inhaler With FF 2-strip Inhaler and With FF/Vilanterol CombinationCompletedNCT01485445Phase 1
- Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine 2830930A Administered in ToddlersCompletedNCT01485406Phase 1
- Gabapentin and Donepezil Combination on Experimental Human Pain ModelsCompletedNCT01485185Phase 1
- Airflow Limitation in Cardiac Diseases in EuropeCompletedNCT01485159
- Pharmacokinetic (PK) Profiles of Tenofovir Disoproxil Fumarate (TDF) 300 mg in Healthy Chinese SubjectsCompletedNCT01480622Phase 1
- Effect of Haemodialysis on the Pharmacokinetics of Ezogabine/Retigabine and Its N-acetyl MetaboliteCompletedNCT01480609Phase 1
- An Investigation of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2245035 in Healthy Volunteers and Allergic Rhinitics.CompletedNCT01480271Phase 1
- Open Label Study of GSK2402968 in Subjects With Duchenne Muscular DystrophyTerminatedNCT01480245Phase 3
- Study on the Incidence of Intussusception (IS) in Children Aged < 12 Months in JapanCompletedNCT01479491
- A Pharmacokinetic Study Investigating the Rate and Extent of Paracetamol Absorption of Three Experimental Sustained Release Pediatric SuspensionsCompletedNCT01476215Phase 1
- A Study to Compare to the Pharmacokinetic Profile of Two Paracetamol FormulationsCompletedNCT01476189Phase 1
- A Pharmacokinetic Study of an Experimental Paracetamol FormulationCompletedNCT01476176Phase 1
- A Study of the Safety and Activity of the MEK Inhibitor Given Together With the AKT Inhibitor to Patients With Multiple Myeloma or Solid Tumor CancersCompletedNCT01476137Phase 1
- Evaluation of Specific Biomarkers in Primary Invasive Breast CancerTerminatedNCT01476111
- A Study to Investigate the Effect of SB-705498 on Chronic CoughCompletedNCT01476098Phase 2
- Evaluating the Utility of the Apoptosis Imaging Biomarker 18F]ML10 in Patients With Non-Hodgkin's Lymphoma(NHL)TerminatedNCT01476085Phase 1
- 31P MRS Ischaemic Exercise Optimisation and COPDCompletedNCT01476072Phase 1
- Pediatric Study to Evaluate Treatment of Persistent Moderate or Severe Asthma With the Association Fluticasone 250 mcg/Dose and Salmeterol 50 mcg/Dose - ADERE PROJECTCompletedNCT01476059Phase 4
- Safety Study of GSK1995057 Given as Single and Repeat Intravenous Doses in Healthy Subjects.CompletedNCT01476046Phase 1
- GSK2251052 Mass Balance in Healthy Adult SubjectsCompletedNCT01475695Phase 1
- Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males.CompletedNCT01471678Phase 1
- GSK2190915 Neutrophilic Asthma StudyCompletedNCT01471665Phase 2
- Japanese Phase 1 Study of MepolizumabCompletedNCT01471327Phase 1
- A Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 and Rilpivirine and Dolutegravir and Rilpivirine in Healthy Adult SubjectsCompletedNCT01467531Phase 1
- Methadone-Dolutegravir (DTG - GSK1349572) Drug Interaction Study.CompletedNCT01467518Phase 1
- An Adaptive Phase I Study to Evaluate the Safety, Efficacy and Dose Responses of Ronacaleret in Healthy Human VolunteersCompletedNCT01466335Phase 1
- A Study to Assess the Relative Bioavailability of Different Formulations of GSK2018682, a Sphingosine-1-phosphate Receptor Subtype 1 Agonist, in Healthy Volunteers.CompletedNCT01466322Phase 1
- Crossover Study to Evaluate the Pharmacokinetics of Ezogabine/Retigabine in Taiwanese SubjectsCompletedNCT01462669Phase 1
- Risk of Urinary Retention With RetigabineTerminatedNCT01462656
- Study to Investigate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Single & Repeat Doses of GSK2269557CompletedNCT01462617Phase 1
- Pilot Study of Patient's Adherence to TYKERB™/TYVERB™ + Capecitabine in Metastatic Breast CancerCompletedNCT01462604
- Physician Liver Function Test (LFT) Monitoring for Tykerb PtsCompletedNCT01462552
- Safety of Inhaled Zanamivir in PregnancyCompletedNCT01462487
- WEUSKOP5410: Observational Study in ENABLE Clinical TrialsCompletedNCT01458080
- A Phase I/IIa, First Time in Human, Study of GSK2636771 in Subjects With Advanced Solid Tumors With Phosphatase and Tensin Homolog (PTEN) DeficiencyCompletedNCT01458067Phase 1
- Effect of Omeprazole and Ritonavir on GSK2336805 Pharmacokinetics in Healthy AdultsCompletedNCT01458054Phase 1
- Meta-Analysis Plan for Pooled Data for Studies VRX-RET-E22-303 and VRX-RET-E22-304CompletedNCT01457989
- Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio VaccineCompletedNCT01457560Phase 3
- Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination CourseCompletedNCT01457547Phase 4
- Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered SeparatelyCompletedNCT01457508Phase 3
- Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered ConcomitantlyCompletedNCT01457495Phase 2
- A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative ColitisCompletedNCT01453491Phase 1
- A Study to Look at How GSK1325756 is Taken up by the Body When Given by Mouth When Stomach Acid is ReducedCompletedNCT01453478Phase 1
- Phase IV Observational Study in Chronic Lymphocytic LeukemiaCompletedNCT01453062
- Phase I Study of Colistin Methanesulfonate SodiumCompletedNCT01449838Phase 1
- Hepatic Monitoring for PazopanibCompletedNCT01449825